Millicent Embry
Impact in
- Oncology top 10%
- CAR-T cell therapy research
- Cancer-related Molecular Pathways
-
- Virus-based gene therapy research
Papers in
- Oncology 5
- HER2/EGFR in Cancer Research 3
- Peptidase Inhibition and Analysis 2
-
- Monoclonal and Polyclonal Antibodies Research 4
- Radiopharmaceutical Chemistry and Applications 2
- Co-authors
- Katherine G. Rendahl (3 shared papers)Daniel Henderson (1 shared paper)Dechao Yu (1 shared paper)Hong Zhang (1 shared paper)Yuanhao Li (1 shared paper)Natalie Nguyen (1 shared paper)Yu Chen (1 shared paper)Jeanette Dilley (1 shared paper)
- Journals
- Molecular Cancer Therapeutics (2 papers)Clinical Cancer Research (2 papers)Blood (2 papers)Oncotarget (2 papers)Hematological Oncology (1 paper)
- Partner nations
- United StatesChinaCanada
In The Last Decade
Millicent Embry
11 papers receiving 423 citations
Peers
Comparison fields: 5 of 49
- Oncology 210
- Genetics 150
- Hematology 46
- Biotechnology 37
- Molecular Biology 269
Countries citing papers authored by Millicent Embry
This map shows the geographic impact of Millicent Embry's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Millicent Embry with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Millicent Embry more than expected).
Fields of papers citing papers by Millicent Embry
This network shows the impact of papers produced by Millicent Embry. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Millicent Embry. The network helps show where Millicent Embry may publish in the future.
Co-authors
The 25 scholars most cited alongside Millicent Embry, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | Antitumor synergy of CV787, a prostate cancer-specific adenovirus, and paclitaxel and docetaxel. | 2001 | 154 |
| 2 | 2007 | 120 | |
| 3 | 2006 | 55 | |
| 4 | 2012 | 51 | |
| 5 | 2018 | 47 | |
| 6 | 2023 | 5 | |
| 7 | 2025 | 3 | |
| 8 | 2015 | 2 | |
| 9 | 2017 | 1 | |
| 10 | 2017 | 1 | |
| 11 | 2025 | 1 | |
| 12 | 2017 | 1 |
About Millicent Embry
Millicent Embry is a scholar working on Oncology, Radiology, Nuclear Medicine and Imaging, Molecular Biology, Hematology and Organic Chemistry, having authored 12 papers that have together received 441 indexed citations. Recurring topics across this work include Monoclonal and Polyclonal Antibodies Research (4 papers), HER2/EGFR in Cancer Research (3 papers), Chronic Myeloid Leukemia Treatments (2 papers), Lymphoma Diagnosis and Treatment (2 papers), Multiple Myeloma Research and Treatments (2 papers), Peptidase Inhibition and Analysis (2 papers), Lung Cancer Treatments and Mutations (2 papers) and Radiopharmaceutical Chemistry and Applications (2 papers). The work is most often cited by research in Oncology (210 citations), Genetics (150 citations), Hematology (46 citations), Biotechnology (37 citations) and Molecular Biology (269 citations). Millicent Embry has collaborated with scholars based in United States, China and Canada. Frequent co-authors include Katherine G. Rendahl, Daniel Henderson, Dechao Yu, Hong Zhang, Yuanhao Li, Natalie Nguyen, Yu Chen, Jeanette Dilley, Tinya J. Abrams and Edward J. Moler. Their work appears in journals such as Molecular Cancer Therapeutics, Clinical Cancer Research, Blood, Oncotarget and Hematological Oncology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.